Biostem Technologies Stock Technical Analysis
| BSEM Stock | USD 6.72 0.77 12.94% |
As of the 6th of February, Biostem Technologies shows the Mean Deviation of 7.63, downside deviation of 7.01, and Risk Adjusted Performance of 0.0809. Biostem Technologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Biostem Technologies, which can be compared to its peers. Please confirm Biostem Technologies jensen alpha, as well as the relationship between the potential upside and skewness to decide if Biostem Technologies is priced correctly, providing market reflects its regular price of 6.72 per share. Given that Biostem Technologies has jensen alpha of 0.9033, we suggest you to validate Biostem Technologies's prevailing market performance to make sure the company can sustain itself at a future point.
Biostem Technologies Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biostem, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BiostemBiostem |
Biostem Technologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biostem Technologies' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biostem Technologies.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in Biostem Technologies on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding Biostem Technologies or generate 0.0% return on investment in Biostem Technologies over 90 days. Biostem Technologies is related to or competes with Rocket Pharmaceuticals, Aura Biosciences, Annexon, Solid Biosciences, Larimar Therapeutics, Altimmune, and Autolus Therapeutics. BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutica... More
Biostem Technologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biostem Technologies' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biostem Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.01 | |||
| Information Ratio | 0.0909 | |||
| Maximum Drawdown | 48.13 | |||
| Value At Risk | (10.97) | |||
| Potential Upside | 22.14 |
Biostem Technologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biostem Technologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biostem Technologies' standard deviation. In reality, there are many statistical measures that can use Biostem Technologies historical prices to predict the future Biostem Technologies' volatility.| Risk Adjusted Performance | 0.0809 | |||
| Jensen Alpha | 0.9033 | |||
| Total Risk Alpha | 0.4845 | |||
| Sortino Ratio | 0.1317 | |||
| Treynor Ratio | 0.6061 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biostem Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biostem Technologies February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0809 | |||
| Market Risk Adjusted Performance | 0.6161 | |||
| Mean Deviation | 7.63 | |||
| Semi Deviation | 6.5 | |||
| Downside Deviation | 7.01 | |||
| Coefficient Of Variation | 1049.43 | |||
| Standard Deviation | 10.17 | |||
| Variance | 103.36 | |||
| Information Ratio | 0.0909 | |||
| Jensen Alpha | 0.9033 | |||
| Total Risk Alpha | 0.4845 | |||
| Sortino Ratio | 0.1317 | |||
| Treynor Ratio | 0.6061 | |||
| Maximum Drawdown | 48.13 | |||
| Value At Risk | (10.97) | |||
| Potential Upside | 22.14 | |||
| Downside Variance | 49.17 | |||
| Semi Variance | 42.21 | |||
| Expected Short fall | (9.90) | |||
| Skewness | 1.17 | |||
| Kurtosis | 1.38 |
Biostem Technologies Backtested Returns
Biostem Technologies is very risky given 3 months investment horizon. Biostem Technologies secures Sharpe Ratio (or Efficiency) of 0.11, which signifies that the company had a 0.11 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.09% are justified by taking the suggested risk. Use Biostem Technologies Mean Deviation of 7.63, risk adjusted performance of 0.0809, and Downside Deviation of 7.01 to evaluate company specific risk that cannot be diversified away. Biostem Technologies holds a performance score of 8 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.58, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biostem Technologies will likely underperform. Use Biostem Technologies sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to analyze future returns on Biostem Technologies.
Auto-correlation | 0.10 |
Insignificant predictability
Biostem Technologies has insignificant predictability. Overlapping area represents the amount of predictability between Biostem Technologies time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biostem Technologies price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Biostem Technologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 1.65 |
Biostem Technologies technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Biostem Technologies Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biostem Technologies volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Biostem Technologies Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biostem Technologies on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biostem Technologies based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Biostem Technologies price pattern first instead of the macroeconomic environment surrounding Biostem Technologies. By analyzing Biostem Technologies's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biostem Technologies's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biostem Technologies specific price patterns or momentum indicators. Please read more on our technical analysis page.
Biostem Technologies February 6, 2026 Technical Indicators
Most technical analysis of Biostem help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biostem from various momentum indicators to cycle indicators. When you analyze Biostem charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0809 | |||
| Market Risk Adjusted Performance | 0.6161 | |||
| Mean Deviation | 7.63 | |||
| Semi Deviation | 6.5 | |||
| Downside Deviation | 7.01 | |||
| Coefficient Of Variation | 1049.43 | |||
| Standard Deviation | 10.17 | |||
| Variance | 103.36 | |||
| Information Ratio | 0.0909 | |||
| Jensen Alpha | 0.9033 | |||
| Total Risk Alpha | 0.4845 | |||
| Sortino Ratio | 0.1317 | |||
| Treynor Ratio | 0.6061 | |||
| Maximum Drawdown | 48.13 | |||
| Value At Risk | (10.97) | |||
| Potential Upside | 22.14 | |||
| Downside Variance | 49.17 | |||
| Semi Variance | 42.21 | |||
| Expected Short fall | (9.90) | |||
| Skewness | 1.17 | |||
| Kurtosis | 1.38 |
Biostem Technologies February 6, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biostem stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 27,009 | ||
| Daily Balance Of Power | 0.57 | ||
| Rate Of Daily Change | 1.13 | ||
| Day Median Price | 6.50 | ||
| Day Typical Price | 6.57 | ||
| Price Action Indicator | 0.60 |
Other Information on Investing in Biostem OTC Stock
Biostem Technologies financial ratios help investors to determine whether Biostem OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biostem with respect to the benefits of owning Biostem Technologies security.